Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study.
- DOI
- 10.1016/j.esmoop.2025.105560
- Published
- 2025 Sep
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2025.105560,
title = {Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study.},
author = {Filippi AR and García Campelo MR and Paoli JB and Kowalski D and Bennati C and Borghetti P and Cortinovis D and Delmonte A and Genova C and Van Hulst S and Mroz RM and Nawrocki S and Toledano I and Tonini G and Agustoni F and Wetherill G and Zhu Z and Perez ID and Foroutanpour K and Georgoulia N and Dziadziuszko R},
year = {2025},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2025.105560},
url = {https://doi.org/10.1016/j.esmoop.2025.105560}
}RIS
TY - JOUR TI - Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study. AU - Filippi AR AU - García Campelo MR AU - Paoli JB AU - Kowalski D AU - Bennati C AU - Borghetti P AU - Cortinovis D AU - Delmonte A AU - Genova C AU - Van Hulst S AU - Mroz RM AU - Nawrocki S AU - Toledano I AU - Tonini G AU - Agustoni F AU - Wetherill G AU - Zhu Z AU - Perez ID AU - Foroutanpour K AU - Georgoulia N AU - Dziadziuszko R PY - 2025 JO - ESMO open DO - 10.1016/j.esmoop.2025.105560 UR - https://doi.org/10.1016/j.esmoop.2025.105560 ER -
APA
AR, F., MR, G. C., JB, P., D, K., C, B., P, B., D, C., A, D., C, G., S, V. H., RM, M., S, N., I, T., G, T., F, A., G, W., Z, Z., ID, P., K, F., N, G., & R, D. (2025). Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study.. ESMO open. https://doi.org/10.1016/j.esmoop.2025.105560
Source records
- pubmed · retrieved 2026-09-27T01:31:30.541Z